Pricing

Zofran Lawsuit Plaintiffs Applaud FDA’s Decision Regarding Folic Acid

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

ZofranLegal.com reports that the plaintiffs involved in the ever growing Zofran litigation are pleased that the FDA has taken steps to ensure that another group of parents won’t have to experience the pain they have - the pain of watching a child suffer from a birth defect.

It was recently announced that the FDA had agreed to allow folic acid to be added to Masa flour. It has long been known that this vitamin, when taken during pregnancy, may help to prevent neural tube defects such as spina bifida. It has also been speculated that it may prevent certain heart defects, cleft lip, and cleft palate. By allowing this addition, the FDA could potentially help thousands of mothers and their unborn children.

Zofran lawsuit plaintiffs know full well how these birth defects can impact a child’s life from the very beginning. Currently, more than 230 lawsuits have been filed against the manufacturers of the anti-emetic drug, GlaxoSmithKline, each one alleging that when Zofran was ingested by an expectant mother, the drug caused a birth defect in an unborn child. Birth defects claimed in these complaints include atrial septal defect, ventricular septal defect, cleft lip, cleft palate, clubfoot, ear deformities, kidney defects, and respiratory distress syndrome.

Parents are seeking to obtain compensation on their child’s behalf for medical expenses, pain and suffering and emotional trauma. In nearly every case, the child required at least one surgical operation in order to correct their defect. Many have been left with permanent scarring and will continue to require medical care for the rest of their lives. Parents have also frequently noted that due to complications of the birth defect, these children are often teased by their peers and have struggled to develop normal social skills.

New complaints are being filed on a regular basis and the attorneys at Monheit Law are working to ensure all parents who believe their child was harmed by Zofran have the opportunity to explore their legal options. Complimentary consultations are currently being offered to qualified families. To learn more, contact Michael Monheit at 877-620-8411.

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

About ZofranLegal.com :

Sponsored by an alliance of attorneys, ZofranLegal.com is a resource for parents, families and birth defect survivors interested in learning more about litigation surrounding the nausea drug Zofran and its link to increased risks of major birth defects.

Contact ZofranLegal.com:

Michael Monheit

1368 Barrowdale Road, Rydal, PA 19046

1-877-620-8411

Social Media:

Additional News Releases From ZofranLegal.com:

April 30, 2016Lawsuit Alleges Invokana Side Effects Can Include Diabetic Ketoacidosis, a Life-Threatening Condition Related to Too Much Acid in the Body

April 29, 2016Zofran Lawsuit Update: Plaintiffs Question Why GSK Hasn’t Faced Stiffer Penalties

April 27, 2016Arkansas Mother Files Zofran Lawsuit Claiming Multiple Defects Caused By Drug

April 25, 2016Zofran Lawsuit Plaintiffs Applaud FDA’s Decision Regarding Folic Acid

April 22, 2016MyFoxBoston News Release Discusses Concerning Zofran Birth Defect Lawsuits And Drug Safety

April 22, 2016Zofran Lawsuit Plaintiffs Note Results Of Japanese Animal Studies Linking Birth Defects To Drug

April 22, 2016A Look Back At America’s First Zofran Lawsuit

April 21, 2016Significant Increase In Birth Defect Development Investigated By Washington State Amid Mounting Zofran Lawsuits

April 21, 2016Zofran Lawsuit Plaintiffs Make Note Of Canadian Label Differences On Drug Which Warn Of Use During Pregnancy

April 20, 2016Zofran Lawsuit Plaintiff Claims Infant’s Cleft Palate, Clubfoot, And Respiratory Distress Caused By Drug Exposure